File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems

TitleAre quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems
Authors
KeywordsProductivity
Quality adjustment
Health expenditures
Medical spending
Net value
Issue Date2020
PublisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/10198/index.htm
Citation
The European Journal of Health Economics, 2020, v. 21 n. 5, p. 689-702 How to Cite?
AbstractImprovements in medical treatment have contributed to rising health spending. Yet there is relatively little evidence on whether the spending increase is “worth it” in the sense of producing better health outcomes of commensurate value—a critical question for understanding productivity in the health sector and, as that sector grows, for deriving an accurate quality-adjusted price index for an entire economy. We analyze individual-level panel data on medical spending and health outcomes for 123,548 patients with type 2 diabetes in four health systems: Japan, The Netherlands, Hong Kong and Taiwan. Using a “cost-of-living” method that measures value based on improved survival, we find a positive net value of diabetes care: the value of improved survival outweighs the added costs of care in each of the four health systems. This finding is robust to accounting for selective survival, end-of-life spending, and a range of values for a life-year or fraction of benefits attributable to medical care. Since the estimates do not include the value from improved quality of life, they are conservative. We, therefore, conclude that the increase in medical spending for management of diabetes is offset by an increase in quality.
Persistent Identifierhttp://hdl.handle.net/10722/281151
ISSN
2020 Impact Factor: 3.689
2015 SCImago Journal Rankings: 0.804
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorEggleston, K-
dc.contributor.authorChen, BK-
dc.contributor.authorChen, C-H-
dc.contributor.authorChen, YI-
dc.contributor.authorFeenstra, T-
dc.contributor.authorIizuka, T-
dc.contributor.authorLam, JTK-
dc.contributor.authorLeung, GM-
dc.contributor.authorLu, J-FR-
dc.contributor.authorRodriguez-Sanchez, B-
dc.contributor.authorStruijs, JN-
dc.contributor.authorQuan, J-
dc.contributor.authorNewhouse, JP-
dc.date.accessioned2020-03-09T09:50:52Z-
dc.date.available2020-03-09T09:50:52Z-
dc.date.issued2020-
dc.identifier.citationThe European Journal of Health Economics, 2020, v. 21 n. 5, p. 689-702-
dc.identifier.issn1618-7598-
dc.identifier.urihttp://hdl.handle.net/10722/281151-
dc.description.abstractImprovements in medical treatment have contributed to rising health spending. Yet there is relatively little evidence on whether the spending increase is “worth it” in the sense of producing better health outcomes of commensurate value—a critical question for understanding productivity in the health sector and, as that sector grows, for deriving an accurate quality-adjusted price index for an entire economy. We analyze individual-level panel data on medical spending and health outcomes for 123,548 patients with type 2 diabetes in four health systems: Japan, The Netherlands, Hong Kong and Taiwan. Using a “cost-of-living” method that measures value based on improved survival, we find a positive net value of diabetes care: the value of improved survival outweighs the added costs of care in each of the four health systems. This finding is robust to accounting for selective survival, end-of-life spending, and a range of values for a life-year or fraction of benefits attributable to medical care. Since the estimates do not include the value from improved quality of life, they are conservative. We, therefore, conclude that the increase in medical spending for management of diabetes is offset by an increase in quality.-
dc.languageeng-
dc.publisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/10198/index.htm-
dc.relation.ispartofThe European Journal of Health Economics-
dc.subjectProductivity-
dc.subjectQuality adjustment-
dc.subjectHealth expenditures-
dc.subjectMedical spending-
dc.subjectNet value-
dc.titleAre quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems-
dc.typeArticle-
dc.identifier.emailLam, JTK: ltkjanet@HKUCC-COM.hku.hk-
dc.identifier.emailLeung, GM: gmleung@hku.hk-
dc.identifier.emailQuan, J: jquan@hku.hk-
dc.identifier.authorityLeung, GM=rp00460-
dc.identifier.authorityQuan, J=rp02266-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1007/s10198-020-01164-1-
dc.identifier.pmid32078719-
dc.identifier.scopuseid_2-s2.0-85079778404-
dc.identifier.hkuros309258-
dc.identifier.volume21-
dc.identifier.issue5-
dc.identifier.spage689-
dc.identifier.epage702-
dc.identifier.isiWOS:000516288800001-
dc.publisher.placeGermany-
dc.identifier.issnl1618-7598-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats